Esketamine for Treatment-Resistant Depression - First FDA-Approved Antidepressant in a New Class.

NEW ENGLAND JOURNAL OF MEDICINE(2019)

Cited 186|Views3
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined